Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 7/20 | 0.36 |
| ▸ | RXRB | P28702 | 7/20 | 0.36 |
| ▸ | RXRG | P48443 | 7/20 | 0.36 |
| ▸ | RBP4 | P02753 | 1/20 | 0.36 |
| ▸ | KMO | O15229 | 2/20 | 0.35 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL137865 | 0.89 | EGFR (0.40) | KDM4EALDH1A1MAPTRXFP1TP53 | |
| SCHEMBL7689792 | 0.81 | HDAC6 (0.37) | HDAC6RXRARXRBRXRGRBP4 | |
| SCHEMBL29365566 | 0.81 | MAOB (0.40) | HDAC6RBP4KMOKDM4EALDH1A1 | |
| SCHEMBL101259 | 0.81 | MAOB (0.40) | HDAC6RBP4KMOKDM4EALDH1A1 | |
| SCHEMBL28535456 | 0.79 | MAOB (0.41) | HDAC6RBP4KDM4EALDH1A1 | |
| SCHEMBL132451 | 0.77 | MAPT (0.32) | KDM4EALDH1A1MAPTRXFP1TP53 | |
| Bumetrizole SCHEMBL8433097 | 0.77 | NPC1 (0.45) | HDAC6RBP4KMOKDM4EALDH1A1 | |
| SCHEMBL5711711 | 0.77 | MAOB (0.39) | HDAC6RXRARXRBRXRGRBP4 | |
| SCHEMBL9420192 | 0.77 | HDAC6 (0.37) | HDAC6RXRARXRBRXRGRBP4 | |
| Propionic Acid SCHEMBL2228683 | 0.76 | NPC1 (0.36) | RBP4KDM4EALDH1A1MAPTRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9034955-B2 | High molecular weight nonpolar benzotriazoles | BASF SE (DE) | 2015-05-19 | — | — | US | disclosed |
| EP-2430089-B1 | HIGH MOLECULAR WEIGHT NON-POLAR BENZOTRIAZOLES | BASF SE (DE) | 2013-07-31 | — | — | EP | disclosed |
| EP-2430089-A2 | HIGH-MOLECULAR NON-POLAR BENZTRIAZOLES | BASF SE (DE) | 2012-03-21 | — | — | EP | disclosed |
| US-20120058974-A1 | Composition comprising pesticide and benzotriazole UV absorbers | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120059095-A1 | HIGH MOLECULAR WEIGHT NONPOLAR BENZOTRIAZOLES | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| WO-2010130752-A2 | HIGH-MOLECULAR NON-POLAR BENZTRIAZOLES | BASF SE (DE) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059095-A1 | HIGH MOLECULAR WEIGHT NONPOLAR BENZOTRIAZOLES | SULT1A1, TPST2, SULT2A1 | HDAC6 879/4885RXRA 2682/4885RXRB 2419/4885 |
| US-20120058974-A1 | Composition comprising pesticide and benzotriazole UV absorbers | DDT, CRY1, PAH | HDAC6 1570/4885RXRA 1341/4885RXRB 1268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.